Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - CAPITAL EXPENDITURES
Capital Expenditures SGMO - Sangamo Therapeutics, Inc.
-21.2 M
LAST VALUE
4.67%
2 YEAR CAGR
13.25%
5 YEAR CAGR
-47.57%
10 YEAR CAGR